Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.

about

Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension.

P2860

Q55259961-F9900165-2609-47BB-9E56-84453BE02A4F

P2860

Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.

Item

http://www.wikidata.org/entity/Q38688645

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Inhibition of Hyaluronan Synth ...... Associated with Lung Fibrosis.

@en

type

Item

label

Inhibition of Hyaluronan Synth ...... Associated with Lung Fibrosis.

@en

prefLabel

Inhibition of Hyaluronan Synth ...... Associated with Lung Fibrosis.

@en

P1476

Inhibition of hyaluronan synth ...... associated with lung fibrosis

@en

P2093

Adriana M Hernandez

http://www.w3.org/2001/XMLSchema#string

Ankit Hanmandlu

http://www.w3.org/2001/XMLSchema#string

Ashrith Guha

http://www.w3.org/2001/XMLSchema#string

Bindu H Akkanti

http://www.w3.org/2001/XMLSchema#string

Fayong Luo

http://www.w3.org/2001/XMLSchema#string

Heather Sweeney

http://www.w3.org/2001/XMLSchema#string

Ian P Horan

http://www.w3.org/2001/XMLSchema#string

Javier Amione-Guerra

http://www.w3.org/2001/XMLSchema#string

Jayakumar Rajadas

http://www.w3.org/2001/XMLSchema#string

Jonathan Davies

http://www.w3.org/2001/XMLSchema#string

P2860

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

Interpretative strategies for lung function tests

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation

Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments.

p63RhoGEF couples Gα(q/11)-mediated signaling to Ca2+ sensitization of vascular smooth muscle contractility.

Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrity

P304

3284-3301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.13947

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

Wenchao Sun

Nicholas W Morrell

Scott D Collum

Harry Karmouty-Quintana

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28688167

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5595757

http://www.w3.org/2001/XMLSchema#string

Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.

about

P2860

P2860

Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932